MDS & KhanLex advises on the GMP-compliant pharmaceutical plant in Mongolia (Jun 2014)

20 Jun MDS & KhanLex advises on the GMP-compliant pharmaceutical plant in Mongolia (Jun 2014)

MDS & KhanLex advises Mongol Em Impex Concern (MEIC) and its parent, Bishrelt Group, on construction and operation of a pharmaceutical plant in Mongolia in the form of a joint venture with South Korea’s Dong-A ST Co. The plant would be the first ever GMP-compliant pharmaceutical manufacturing factory in Mongolia.

MEIC is a leading pharmaceutical distributor in Mongolia with the largest network of pharmacies, warehouses and pharm markets across the country.

We’re happy to have assisted MEIC and its parent, Bishrelt Group, on this transaction” said Commercial partner Enkhbat B. who led on this deal. “The transaction was significant in that it involved a large scale cross-border transfer and operation of intellectual property. We’re also pleased to have been able to support Dong-A, producer of well-known Bacchus energy drinks, in its continued expansion in Mongolia“.  The MDS & KhanLex team also included associate Uchralbayar I..